Matches in Wikidata for { <http://www.wikidata.org/entity/Q66063122> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q66063122 description "clinical trial" @default.
- Q66063122 description "ensayu clínicu" @default.
- Q66063122 description "klinisch onderzoek" @default.
- Q66063122 description "клінічне випробування" @default.
- Q66063122 name "A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis" @default.
- Q66063122 name "A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis" @default.
- Q66063122 type Item @default.
- Q66063122 label "A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis" @default.
- Q66063122 label "A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis" @default.
- Q66063122 prefLabel "A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis" @default.
- Q66063122 prefLabel "A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis" @default.
- Q66063122 P1050 Q66063122-C5646EAC-E200-480B-9824-1B1259C06F86 @default.
- Q66063122 P1132 Q66063122-D638F18B-44CA-4299-8617-9DD178432BA6 @default.
- Q66063122 P1476 Q66063122-9D9D9B75-997D-4B3F-A2F3-30A55366244A @default.
- Q66063122 P1813 Q66063122-D9044B56-72AB-4FAF-927D-E42CF98B8F89 @default.
- Q66063122 P2899 Q66063122-C34BB0D3-45D7-4DCA-ADD6-3FDEC30FD4EC @default.
- Q66063122 P3098 Q66063122-69E7C813-CBF6-4E3D-8665-EFA2E824A2C7 @default.
- Q66063122 P31 Q66063122-1718B29E-BF82-4BA9-878D-A7268FFB52F1 @default.
- Q66063122 P580 Q66063122-52D8B407-58BA-4894-98DC-0A4BF621307A @default.
- Q66063122 P582 Q66063122-BE9DC6DC-C4CD-4B73-9137-88870069F8A1 @default.
- Q66063122 P6099 Q66063122-C66D6DD3-5CFE-4AA4-B62C-EFAEC5252838 @default.
- Q66063122 P8363 Q66063122-AA6A2D38-AD74-4B7D-ABCC-4EF028457B89 @default.
- Q66063122 P1050 Q170990 @default.
- Q66063122 P1132 "+1045" @default.
- Q66063122 P1476 "A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis" @default.
- Q66063122 P1813 "BE VITAL" @default.
- Q66063122 P2899 "+18" @default.
- Q66063122 P3098 "NCT04009499" @default.
- Q66063122 P31 Q30612 @default.
- Q66063122 P580 "2019-08-01T00:00:00Z" @default.
- Q66063122 P582 "2024-09-01T00:00:00Z" @default.
- Q66063122 P6099 Q42824827 @default.
- Q66063122 P8363 Q78089383 @default.